Get the Stockscreener App
1.50
2.90%
-0.05
Soligenix Inc stock is traded at $1.50, with a volume of 35,725.
It is down -2.90% in the last 24 hours and up +9.06% over the past month.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
See More
Previous Close:
$1.55
Open:
$1.55
24h Volume:
35,725
Relative Volume:
0.01
Market Cap:
$6.47M
Revenue:
$960.60K
Net Income/Loss:
$-7.10M
P/E Ratio:
-0.1984
EPS:
-7.56
Net Cash Flow:
$-8.00M
1W Performance:
-3.53%
1M Performance:
+9.06%
6M Performance:
-21.78%
1Y Performance:
-61.01%
1-Day Range:
$1.51
$1.5599
1-Week Range:
$1.49
$1.61
52-Week Range:
$1.09
$6.2299
Soligenix Inc Stock (SNGX) Company Profile
Name
Soligenix Inc
Sector
Industry
Phone
609-538-8200
Address
29 EMMONS DRIVE, PRINCETON
Compare SNGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNGX
Soligenix Inc
|
1.51 | 12.97M | 960.60K | -7.10M | -8.00M | -7.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.18 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.84 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Soligenix Inc Stock (SNGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-20 | Downgrade | Dawson James | Buy → Neutral |
| Jan-31-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Aug-14-17 | Reiterated | Maxim Group | Buy |
| Jul-17-17 | Initiated | H.C. Wainwright | Buy |
Soligenix Inc Stock (SNGX) Latest News
Will Soligenix Inc. stock benefit from infrastructure spendingJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Is Soligenix Inc. (DOA) stock in buy zone after pullbackForecast Cut & AI Driven Stock Movement Reports - newser.com
How Soligenix Inc. (DOA) stock compares with tech leaders2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com
Is Soligenix Inc. (DOA) stock good for long term investingJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
Why Soligenix Inc. (DOA0) stock stays on top picks2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com
Can Soligenix Inc. stock deliver sustainable ROE2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Will Soligenix Inc. (DOA) stock maintain strong growthJuly 2025 Levels & Safe Capital Investment Plans - newser.com
Is Soligenix Inc. (DOA) stock a momentum leaderEarnings Overview Summary & Weekly Sector Rotation Insights - newser.com
What sentiment indicators say about Soligenix Inc. stockMarket Sentiment Report & Daily Profit Focused Screening - newser.com
Visual analytics tools that track Soligenix Inc. performanceWall Street Watch & Safe Capital Growth Tips - newser.com
Why Soligenix Inc. (DOA0) stock is trending on social mediaJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Will Soligenix Inc. (DOA0) stock top growth indexesEarnings Overview Summary & Weekly Breakout Stock Alerts - newser.com
Will Soligenix Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Is Soligenix Inc. stock a buy in volatile marketsJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com
Is Soligenix Inc. trending in predictive chart modelsJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Applying Wyckoff theory to Soligenix Inc. stockJuly 2025 Outlook & High Accuracy Trade Alerts - newser.com
Published on: 2025-11-01 03:35:33 - newser.com
Is Soligenix Inc. stock attractive for income investors2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
Is Soligenix Inc. stock a buy on dipsMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-10-31 04:43:24 - newser.com
Understanding Soligenix Inc.’s price movementWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Soligenix’s Promising Phase 2 Study on SGX302 for Psoriasis: A Potential Game-Changer - TipRanks
Soligenix’s Phase 3 Study on HyBryte™: A Potential Game-Changer for CTCL Treatment - MSN
Published on: 2025-10-30 06:40:41 - newser.com
Published on: 2025-10-30 04:26:59 - newser.com
Why Soligenix Inc. stock could outperform in 20252025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Soligenix Inc Stock (SNGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):